RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RTTR

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/11/09	21 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/11/09	20 : 22	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/11/08	08 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/11/07	01 : 58	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/11/06	21 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock ...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/11/06	07 : 30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/10/31	22 : 21	GlobeNewswire Inc.	Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Sto...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/10/09	21 : 30	GlobeNewswire Inc.	Ritter Pharmaceuticals Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Pati...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/09/20	03 : 21	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/08/29	02 : 31	GlobeNewswire Inc.	Ritter Pharmaceuticals to Present at 20th Annual HC Wainwright Global Investment Conference on September 5, 2018	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/08/21	06 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/08/15	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/08/15	05 : 41	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/08/15	05 : 15	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Progress	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/07/02	19 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/06/28	06 : 23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/06/27	20 : 05	GlobeNewswire Inc.	Ritter Pharmaceuticals Announces Appointment of Andrew J. Ritter as Chief Executive Officer	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/06/27	20 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Initiates First Pivotal Phase 3 Trial for RP-G28 for the Treatment of Lactose Intolerance	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/06/05	21 : 30	GlobeNewswire Inc.	Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive Disease Wee...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/29	19 : 15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/29	19 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial Officer	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/26	06 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/26	06 : 24	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/26	05 : 07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/22	21 : 30	GlobeNewswire Inc.	Ritter Pharmaceuticals to Present Two Posters at Digestive Disease Week 2018 Highlighting Treatment Data of RP-G28 for Lactos...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/16	06 : 45	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/16	06 : 45	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/16	05 : 10	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Updates	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/15	20 : 03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/05/07	19 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc